Back
Novo Nordisk A/S 10K Form
Sell
50
NVO
Novo Nordisk A/S
Last Price:
126.70
Seasonality Move:
1.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVO News And Ratings
See the #1 stock for the next 7 days that we like better than NVO
NVO Financial Statistics
Sales & Book Value
| Annual Sales: | $33.72B |
|---|---|
| Cash Flow: | $772.71M |
| Price / Cash Flow: | 78.22 |
| Annual Sales: | $3.21 |
| Price / Book: | 39.79 |
Profitability
| EPS (TTM): | 2.89680 |
|---|---|
| Net Income (TTM): | $12.99B |
| Gross Margin: | $28.53B |
| Return on Equity: | 95.26% |
| Return on Assets: | 30.93% |
Novo Nordisk A/S Earnings Forecast
Key Novo Nordisk A/S Financial Ratios
- The Gross Profit Margin over the past 40 years for NVO is 84.60%.
- The Selling, General & Administrative Expenses for NVO have been equal to 26.52% of Gross Profit Margin.
- The Research & Development expenses have been 13.97% of Revenue.
- The Interest Expense is 0.65% of Operating Income.
- The Net Earning history of NVO is 36.03% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 35 years.
Novo Nordisk A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NVO |
| CUSIP: | 670100 |
| Website: | novonordisk.com |
Debt
| Debt-to-Equity Ratio: | 0.27 |
|---|---|
| Current Ratio: | 0.7 |
| Quick Ratio: | 0.49 |
Price-to-Earnings
| Trailing P/E Ratio: | 47.3 |
|---|---|
| Forward P/E Ratio: | 29.99 |
NVO Technical Analysis vs Fundamental Analysis
Sell
50
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a Sell
The current Novo Nordisk A/S [NVO] share price is $127.86. The Score for NVO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.